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Abstract 
In vivo fluorescence imaging in the second near-infrared window (1.0-1.7 m) can afford deep 
tissue penetration and high spatial resolution, owing to the reduced scattering of long-wavelength 
photons. Here, we synthesize a series of low-bandgap donor/acceptor copolymers with tunable 
emission wavelengths of 1050-1350 nm in this window. Non-covalent functionalization with 
phospholipid-polyethylene glycol results in water-soluble and biocompatible polymeric 
nanoparticles, allowing for live cell molecular imaging at > 1000 nm with polymer fluorophores 
for the first time. Importantly, the high quantum yield of the polymer allows for in vivo, deep-
tissue and ultrafast imaging of mouse arterial blood flow with an unprecedented frame rate of > 
25 frames per second. The high time resolution results in spatially and time resolved imaging of 
the blood flow pattern in cardiogram waveform over a single cardiac cycle (~ 200 ms) of a 
mouse, which has not been observed with fluorescence imaging in this window before.  
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Introduction 
In vivo biological imaging in the second near-infrared window (NIR-II, 1.0-1.7 m) has attracted 
much interest recently
1-8
 owing to salient advantages over imaging in the visible (400-750 nm) 
and the conventional near-infrared (NIR, 750-900 nm) regions. Detecting longer wavelength 
photons in the NIR-II affords reduced photon scattering in biological tissues accompanied by 
lower autofluorescence, leading to higher spatial resolution at deeper tissue penetration depths.
9
 
To date, single-walled carbon nanotubes (SWNTs)
1-3,10-14
, semiconducting quantum dots 
(QDs)
6,7,15-17
, rare-earth doped nanoparticles
8
 and nanoparticles made of small organic 
molecules
18
 are fluorophores used for fluorescence imaging in the NIR-II region. These NIR-II 
agents can be functionalized with hydrophilic molecules to afford biocompatibility for 
intravenous administration and can be gradually cleared out from the body without obvious acute 
or chronic toxicity in animal studies.
16,19,20
 However, shortcomings of existing NIR-II 
fluorophores include relatively low fluorescence quantum yield
1,8,21
, unfavorably short emission 
wavelength
18
 and potential toxicity due to heavy metals in QDs.
6,7,15-17
 A much wider range of 
fluorophores could be developed to tackle these problems. An ideal fluorophore developed for 
NIR-II biological imaging should allow for tunable excitation and emission wavelengths in the > 
1000 nm NIR-II region with a high fluorescence quantum yield and high biocompatibility.  
Here we report the synthesis of conjugated polymers with intrinsic fluorescence > 1000 
nm through donor-acceptor (D-A) alternating copolymerization, an effective way of synthesizing 
polymers with tunable bandgap energy in the NIR and at even longer wavelength regions.
22-29
 By 
copolymerization of an electron-donating monomer benzo[1,2-b:3,4-b']difuran and an electron-
withdrawing monomer fluorothieno-[3,4-b]thiophene, we derive a brightly fluorescent 
copolymer, poly(benzo[1,2-b:3,4-b']difuran-alt-fluorothieno-[3,4-b]thiophene) (named ‘pDA’) 
with fluorescence emission at ~1050 nm with a large Stokes shift of ~ 400 nm and a high 
fluorescence quantum yield of ~1.7%, much higher than the quantum yield of typical carbon 
nanotubes (~0.4%) used previously.
3
 We non-covalently functionalize the polymer with a 
PEGylated surfactant to afford water solubility and biocompatibility.  We successfully tune the 
emission wavelength of the conjugated polymer fluorophores from 1050 nm to 1350 nm, and 
demonstrate the first in vitro and in vivo biological imaging in the > 1000 nm window using 
conjugated polymer fluorophores. 
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Results 
Synthesis of NIR-II Fluorescent pDA-PEG Nanoparticles. The pDA polymer was synthesized 
through a copolymerization reaction of two monomers, 1-(4,6-dibromo-3-fluorothieno[3,4-
b]thiophen-2-yl)nonan-1-one and 2, 6-bis(trimethyltin)-4,8-bis (2-ethylhexyloxy)benzo[1,2-
b;3,4-b’]difuran.26 Fluorine was introduced into the thienothiophene unit to tune the fluorescence 
to long wavelengths (Fig. 1). The pDA polymer was characterized by 
1
H NMR spectroscopy (see 
Methods and Supplementary Figs. 1-4) and gel permeation chromatography (GPC). The 
average molecular weight (Mn) of the polymer was ~16 kDa (see Methods and Supplementary 
Fig. 5). We dissolved the as-made pDA polymer in tetrahydrofuran (THF) and then mixed it 
with an aqueous solution of a biocompatible surfactant of PEGylated phospholipid [DSPE-
mPEG (5 kDa)]
1,3,19
 (see Methods). The mixture was dialyzed against water to remove THF, 
resulting in a stable aqueous solution of supramolecular conjugate comprised of hydrophobic 
core of pDA and hydrophilic shell of DSPE-mPEG coating (Fig. 2a; named as pDA-PEG).  
Atomic force microscopy (AFM) revealed the size distribution of pDA-PEG 
nanoparticles (Fig. 2b) with an average size of 2.9 nm when dried on a silicon surface 
(Supplementary Fig. 6). The UV-Vis-NIR absorption spectrum of the as-made pDA-PEG 
solution in water exhibited an absorption peak at 654 nm, while the fluorescence emission 
spectrum showed a main emission peak at 1047 nm, suggesting a large Stokes shift of ~ 400 nm 
(Fig. 2c). The pDA copolymer has been reported to have red-shifted absorption and emission 
compared to the corresponding homopolymers, due to the formation of a charge-transfer 
structure between the electron donor and acceptor units.
26,27,30
 The fluorescence quantum yield of 
pDA-PEG in a solution (Fig. 2d) under an excitation of 808 nm was ~ 1.7%, measured against a 
standard IR-26 dye as a reference
31,32
 (Supplementary Fig. 7a-f, where the excitation of 808 nm 
was intentionally chosen to balance absorption and scattering to afford maximum penetration 
depth of excitation light for in vivo imaging). The quantum yield was much higher than that of 
typical nanotubes (~0.4%) (Supplementary Fig. 7g-i).  The pDA-PEG exhibited high 
photostability in phosphate buffer saline (PBS) and fetal bovine serum with negligible decay 
under continuous excitation for 1 h (Fig. 2e-f and Supplementary Fig. 8). These results 
suggested pDA-PEG as an aqueous soluble, photo-stable and high brightness NIR-II fluorescent 
agent suited for biological imaging.  
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Molecular Imaging of Cells with pDA-PEG in NIR-II. We investigated pDA-PEG as a 
fluorescent label capable of targeting specific molecules on cell surfaces for performing 
molecular imaging of cancer cells through functionalization of pDA with targeting ligands. We 
made pDA-PEG-NH2 using an amine-terminated phospholipid surfactant, DSPE-PEG-NH2.
33,34
 
Cetuximab (Erbitux) antibodies were then thiolated and conjugated to pDA-PEG-NH2 via 
standard crosslinking reaction between the -NH2 groups on the polymer and -SH groups on the 
thiolated antibody (see Methods). Then the pDA-PEG-Erbitux was applied to target the 
epidermal growth factor receptors (EGFR) on the cell membranes of EGFR-positive breast tumor 
MDA-MB-468 cells while the EGFR-negative brain tumor U87-MG cells were used as a 
negative control.
15
 Cell imaging in NIR-II detected > 1000 nm fluorescence of pDA-PEG-
Erbitux (Fig. 3) selectively on the EGFR-positive MDA-MB-468 cells and not on the negative 
U87-MG cells, showing a positive/negative ratio of ~5.8. Thus, the pDA-PEG was made into an 
NIR-II fluorescent agent capable of recognizing and staining live cells with molecular specificity. 
This opened up the possibility of molecular imaging with conjugated copolymers in vitro and in 
vivo, which would not be attainable by structural imaging techniques such as ultrasound and 
optical coherence tomography (OCT).
35,36
 
 
Ultrafast Blood Flow Tracking with pDA-PEG in NIR-II. Next, we performed in vivo mouse 
blood vessel imaging by detecting the > 1000 nm fluorescence of intravenously injected pDA-
PEG solutions. Owing to the bright fluorescence of pDA-PEG with a 4-fold higher quantum 
yield (1.7%) than nanotube fluorophores
3
 (quantum yield ~0.4%), we were able to dynamically 
image and track real-time arterial blood flow in the mouse hindlimb with a much shorter 
exposure time (~20 ms) than previously possible (~ 100 ms) in the NIR-II window.
3
 Immediately 
following a tail-vein injection of 200 L solution of pDA-PEG, we performed video-rate 
imaging of the left hindlimb of a mouse in the supine position with an ultrafast frame rate of 25.6 
frames per second (fps) compared to the previously achievable 5.3 fps.
3
 Such a high imaging 
speed enabled clear observation of the fast-moving flow front in the femoral artery as the NIR-II 
emitting pDA-PEG entered the hindlimb (Supplementary Movie 1 and Fig. 4a). The average 
femoral blood flow velocity was quantified by plotting the distance traveled by the flow front as 
a function of time, showing an overall linear increase with an average blood velocity of 4.36 
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cm·s
-1
 (Fig. 4b), consistent with measurement by ultrasound (4~7 cm·s
-1
).
3
 This represented the 
first in vivo blood flow velocity measurement by direct tracking through real-space imaging of 
fast-moving flow front on the millisecond scale using NIR-II fluorescence. 
Interestingly, high time-resolution analysis of blood flow-front position versus time 
revealed periodic variations in instantaneous velocity over time with a period of 150-200 ms, 
showing oscillations between the highest instantaneous blood velocity of ~8 cm·s
-1
 and the 
lowest blood velocity of ~2 cm·s
-1
, corresponding to the ventricular ejection (systolic) and 
ventricular relaxation (diastolic) phases respectively of a single cardiac cycle (Fig. 4c). The 
observation of such a rapid periodic oscillation in the femoral blood velocity was entirely owed 
to the high time resolution of 20 ms, much shorter than the cardiac cycle of ~ 200 ms. The fast 
arterial blood flow (average speed ~ 4.36 cm·s
-1
) passed through the entire femoral artery (length 
~2 cm) within two cardiac cycles (~400 ms). At longer times post injection, the same hindlimb 
imaged at 39 s post injection (p.i.) showed full perfusion of the injected NIR-II pDA-PEG 
fluorescent polymer into the femoral artery (Fig. 4d).  
To further glean the oscillating blood flow front with high time-resolution, we selected a 
region of interest (ROI) of the femoral artery and analyzed the NIR-II fluorescence intensity as a 
function of time (Fig. 5a). We observed evenly spaced intensity humps over a linearly increasing 
baseline (Fig. 5b), with the humps corresponding to the systolic phases of cardiac cycles of the 
mouse and the increasing baseline due to increased overall perfusion of pDA-PEG fluorophore 
into the artery vessel.
3
 By subtracting the linear rise from the intensity vs. time curve, we 
observed clear consecutive intensity spikes in the time course due to periodic ventricular 
ejections (Fig. 5c). Further, the linear-baseline subtracted fluorescence intensity vs. time was 
made into a movie that clearly showed the blood flow variations over the two phases of each 
heartbeat (Figs. 5d-j & Supplementary Movie S2). The blood flow vs. time showed a similar 
cardiogram waveform (Fig. 5c) as previous Doppler ultrasound measurement,
37
 demonstrating 
fluorescence imaging could help visualize rapid blood flow changes in real-space and real-time 
within a single cardiac cycle of mouse.  
It is also interesting to note that the dots observed along the femoral artery in the 
baseline-subtracted images (Figs. 5f-h) were at fixed positions over time and corresponded to 
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local higher NIR-II intensity regions along the femoral artery. These high intensity local regions 
were found to coincide with locations along the vessel with slightly larger vessel diameters (by 
~20%) of the lumen measured with the vessel image. That is, more NIR-II pDA-PEG 
fluorophores in the blood were filled into a larger lumen and thus exhibited higher NIR-II 
intensity (Supplementary Fig. 9). From the NIR-II fluorescence oscillations with an average 
period of 206.7 ms per cardiac cycle (Fig. 5k), we measured a heart rate of 290 beats per minute 
for the mouse, which agreed with previous results via cardiac gating.
38
 Thus, the high-temporal 
and high-spatial resolution NIR-II imaging afforded by the high brightness of the conjugated 
polymer led to remarkably rich details of blood flows and cardiac cycles in vivo.  
 
Discussion 
In vivo fluorescence imaging of live animals in the NIR-II region benefits from deeper 
penetration of up to a few millimeters inside the body and reduced scattering of photons that 
scales inversely proportional with wavelength as ~-w (w = 0.22-1.68) in biological tissues.3,9 
Conjugated polymers have been widely used in organic solar cells,
26,39
 light-emitting diodes
40,41
 
and organic electronics.
42,43
 Fluorescent imaging with conjugated polymers has been limited to 
emission wavelength < 900 nm.
44-46
 Our current work developed the NIR-II agent with > 1000 
nm fluorescence based on conjugated polymers for biological imaging both in vitro and in vivo.
47
 
The facile synthetic route of donor-acceptor copolymers could allow further tuning of the optical 
properties of the polymers through modifying the donor-acceptor structures (Supplementary Fig. 
10) and the length of the copolymer. A more electron-donating donor and a more electron-
withdrawing acceptor typically result in smaller band gap of the copolymer,
48
 and a longer 
copolymer exhibits reduced band gap due to a greater delocalization of -electrons.30 This could 
lead to a library of polymers with tunable excitation and emission wavelengths for NIR-II 
imaging (see Supplementary Fig. 10 for several polymers synthesized thus far). With such 
development, we envisage fluorophores with different emission wavelengths in the 1.0-1.7 m 
NIR-II window, allowing for multicolor molecular imaging of different biomarkers. Also, further 
improved penetration depth could be achieved in vivo by tuning the emission wavelength. 
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A salient advantage of the pDA-PEG polymer as an NIR-II fluorophore for in vivo live 
animal imaging is its much higher quantum yield (~1.7%) than SWNTs (~0.4%) previously used 
for hindlimb blood flow tracking.
3
 This allows for much faster (20 ms exposure time vs. previous 
100 ms)
3
 video-rate imaging of dynamic changes in the blood flow labeled by NIR-II 
fluorophore, pushing the limit of temporal resolution to a previously unattainable level of > 25 
fps (the instrument frame rate limit is 50 fps due to an overhead time of 19 ms). Although the 
pDA-PEG polymer has similar quantum efficiency (~1.7%) to nanoparticles of small organic 
molecules (~1.8%),
18
 since the major peak of the small organic molecule nanoparticles is located 
at ~920 nm while the major peak of pDA-PEG polymer is at ~1050 nm, the pDA-PEG polymer 
has a greater portion of emitted photons in the >1000 nm NIR-II region (~70%) than the small 
molecule nanoparticles (~40%).
18
 Taken together, the high fluorescence quantum yield, red-
shifted fluorescence emission in the NIR-II region and low density of the pDA polymer require 
10~100× lower mass dose of injection than previous NIR-II fluorophores (such as SWNTs
1-3,9-12
, 
QDs
6,7,15-17
, rare-earth doped nanoparticles
8
 and nanoparticles incorporating organic molecules
18
)  
to reach the same in vivo imaging quality, and allow for dynamic fluorescence imaging with 
much shorter exposure time and higher temporal resolution. This high temporal resolution well 
exceeds the heart rate of mice (~5 beats per second, or ~ 200 ms per cycle) by 5 times, 
eliminating the need for cardiac gating typically required for low-frame-rate cardiovascular 
imaging techniques.
38,49
  
Previous fluorescence imaging and tracking of blood flow usually require the removal of 
scattering tissue over the vessels of interest to afford higher spatial resolution, and gating devices 
to eliminate image blurring due to cardiac and respiratory motions on a faster time scale than the 
temporal resolution of image acquisitions (~10 fps).
38,50
 Ultrasound imaging and optical 
coherence tomography (OCT) with ultrafast image acquisition rate (kHz~MHz) have shown the 
advantages of measuring fast blood flow and cardiac cycles,
51-53
 but the spatial resolution (in the 
10 m ~ 1 mm range)  and signal-to-noise ratio are sub-optimal due to long wavelengths54 and 
speckles.
55,56
 Here, by utilizing NIR-II fluorescence with reduced tissue scattering and an 
ultrafast frame rate of >25 fps, we have enabled simultaneous blood velocity and cardiac cycle 
measurements as well as high resolution imaging of blood vessels 1-2 mm deep under otherwise 
highly scattering skin tissues.
57
 We have also proved the concept that the polymer-based NIR-II 
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fluorophores can be used to track blood flow in capillaries with sub-10 m diameters 
(Supplementary Fig. 11a), which are well below the spatial resolutions of traditional ultrasound 
and OCT. Based on the capillary blood flow tracking images, we measured the capillary blood 
velocity to be ~55.2 m·s-1 (Supplementary Fig. 11b), in good agreement with previous 
studies.
58,59
 The dynamic range of blood velocity measurement in our NIR-II imaging system 
using the pDA fluorophores is derived as 0 to 640 mm/s based on the brightness of the 
fluorophore and the detector sensitivity (Supplementary Note 1). In addition, we have shown 
that the pDA-PEG fluorophores can be used to track regional blood flow and redistribution as a 
result of increased metabolic demand after heat-induced inflammation of the tissue 
(Supplementary Fig. 12), providing a direct diagnostic tool for visualizing the metabolic 
difference of the tissue. 
The heavy-metal-free nature of fluorescent conjugated polymers bodes well for 
potentially low toxicity agents for in vivo applications.
60
 In a cellular toxicity study, we found 
that the toxicity of pDA-PEG nanoparticles depended on the surfactant coating, and a surfactant 
with branched PEG exhibited alleviated toxicity (see Methods). The mice injected with pDA-
PEG were monitored over a period of up to 2 months without showing obvious toxic effects or 
health problems. We also attempted tuning the size of the pDA-PEG nanoparticles and obtained 
the smallest pDA-PEG with an average hydrodynamic size of < 6 nm (Supplementary Fig. 13, 
and also see Methods for more information). Systematic investigation is required to study the 
long term fate and toxicology of pDA-PEG nanoparticles, which is beyond the scope of the 
current work. 
Real-time hemodynamic imaging could be of central importance to better understanding 
various cardiovascular diseases and designing treatment strategies.
61
 An ideal NIR-II fluorescent 
agent capable of achieving hemodynamic imaging with high spatial and temporal resolutions 
should have tunable emission wavelength in the >1000 nm region to minimize tissue scattering, 
high fluorescence quantum efficiency (> 5%) for ultra-short imaging exposure time. The current 
work opens up future research to achieve these goals, and could eventually lead to NIR-II 
fluorescence agents suitable for clinic use.   
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Methods 
Synthesis of pDA copolymer. The synthesis of monomers M1 and M2 can be found in previous 
publications.
62-64
 For the synthesis of the pDA copolymer, 0.091 g of monomer M1 (0.2 mmol), 
0.148 g of the monomer M2 (0.2 mmol) and 15 mL of anhydrous toluene were mixed in a two-
neck flask. The solution was flushed with N2 for 10 min, and 15 mg of Pd(PPh3)4 was added into 
the flask. Then the solution was flushed with N2 for another 25 min. The two-neck flask was 
placed in an oil bath and heated up carefully to 110 °C. The mixture was stirred for 24 h at 
110 °C under N2 atmosphere. After the reaction was complete, the mixture was allowed to cool 
down to room temperature, and the polymer was precipitated by adding 100 mL of methanol and 
filtered through a Soxhlet thimble. Soxhlet extraction was performed with methanol, hexanes and 
chloroform. 80 mg of the polymer was obtained as a green solid from the chloroform fraction by 
rotary evaporation, and dried under vacuum overnight with a moderate yield of 56%.  
Characterizations of monomers and pDA copolymer. All compounds, including the 
monomers M1 and M2, and the pDA copolymer, were characterized by nuclear magnetic 
resonance (NMR) spectroscopy. The 
1
H NMR and 
19
F NMR spectra were measured on a Bruker 
AV-400 spectrometer at room temperature. Chemical shifts were described as  values (ppm), 
where tetramethylsilane (TMS) was used as an internal reference. Splitting patterns were labeled 
as s (singlet), d (doublet), t (triplet), m (multiplet) and br (broad). As such, the NMR spectral 
assignments for the two monomers M1 and M2, as well as the product polymer, are given as 
follows, 
Monomer M1:  
1
H NMR (400 MHz, CDCl3): δ 2.95 (t, 2H), 1.76 (m, 2H), 1.39-1.30 (m, 10H), 0.91 (t, 3H). 
19
F NMR (400 MHz, CDCl3): -129 ppm (s, Ar-F) 
Monomer M2: 
1
H NMR (400 MHz, CDCl3): δ 7.06 (s, 2H), 4.35 (d, 4H), 1.78 (m, 2H), 1.37-1.70 (m, 16 H), 
0.96-1.03 (m, 12 H), 0.44 (s, 18 H). 
Polymer pDA: 
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1
H NMR (400 MHz, CDCl3): δ 6.80 (br, 2H), 4.31 (br, 4H), 3.06 (br, 2H), 2.01-1.21 (br, 30H), 
0.81-1.21 (br, 15H). 
Elemental analysis of the pDA copolymer was performed on a Flash EA 1112 elemental analyzer. 
Elemental composition of pDA copolymer was calculated based on the molecular formula 
(C41H53FO5S2)n  as C: 69.26%; H: 7.80%; O: 11.25%, and compared to measured elemental 
composition by the elemental analyzer: C, 70.08%; H, 7.73%; O, 11.09%.  
Molecular weight and polydispersity of the pDA copolymer were measured by gel permeation 
chromatography (GPC). The number-average molecular weights (Mn), weight-average molecular 
weights (Mw) and polydispersity index (PDI, Mw/Mn) were determined using polystyrene as the 
reference. Measurements were carried out using a Waters 515 HPLC pump, a Waters 2414 
differential refractometer, and three Waters Styragel columns (HT2, HT3 and HT4) with THF as 
the eluent at a flow rate of 1.0 mL·min
-1
 at a temperature of 35 °C. 
Preparation of pDA-PEG and pDA-PEG-NH2. The as-synthesized pDA polymer was 
dissolved in THF at a mass concentration of 75 g·mL-1 and mixed with an aqueous solution of 
DSPE-mPEG(5 kDa) (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethyleneglycol, 5000)], Laysan Bio) at a concentration of 1.1 mg·mL
-1
 with a 1:9 
volume ratio for making the pDA-PEG, or with an aqueous solution of DSPE-PEG-NH2 (5 kDa) 
(1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethyleneglycol, 5000)], 
Laysan Bio) at 1.1 mg·mL
-1
 with a 1:9 volume ratio for making the pDA-PEG-NH2. The pDA 
polymer remained soluble in the mixed solvent without any precipitation. Then the mixture was 
dialyzed against water to remove THF and make a THF-free, clear aqueous solution of pDA-
PEG or pDA-PEG-NH2 polymers. To remove aggregates formed during dialysis, the suspension 
was ultracentrifuged for 30 min at 300,000 g and only the supernatant was retained. Free, 
unbound surfactant in the solution was removed through 30-kDa centrifugal filters (Amicon) 
without causing any instability to the pDA-PEG polymers, suggesting the hydrophobic core of 
pDA and the hydrophilic shell of DSPE-mPEG were making a strongly-held complex. 
Preparation of pDA-PEG-Erbitux bioconjugate. A 200 L solution of pDA-PEG-NH2 after 
excess surfactant removal was concentrated to a mass concentration of 320 g·mL-1, determined 
by a mass extinction coefficient of 30.4 L·g
-1
·cm
-1
 at its peak absorbance in the UV-Vis-NIR 
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absorption spectrum. Then this solution was mixed with 1 mM sulfo-SMCC for 1 h in PBS at pH 
7.4. On the other hand, 12.3 L of Erbitux solution (Bristol-Myers Squibb) at a concentration of 
2 mg·mL
-1
 (~13.3 M) was mixed with a 1.64 L solution of Traut’s reagent (Sigma) at 1 mM 
concentration and 86 L PBS solution. In the mixture the molar ratio of Erbitux antibody to 
Traut’s reagent was 1:10. The mixture of Erbitux antibody and Traut’s reagent was allowed to 
react for 1.5 h at room temperature. After removing excess sulfo-SMCC from the polymer 
solution and excess Traut’s reagent from the antibody solution by filtration through 30-kDa 
centrifugal filters (Amicon), the two solutions were mixed and allowed to react for 2 days in PBS 
at 4 °C to make the pDA-PEG-Erbitux bioconjugate. 
Spectral Charaterizations of pDA-PEG. UV-Vis-NIR absorption spectrum of pDA-PEG 
polymer in water was measured by a Cary 6000i UV-Vis-NIR spectrophotometer, background-
corrected for contribution from water. The measured range was 400-900 nm. The NIR-II 
fluorescence spectrum was taken using a home-built NIR-II spectroscopy setup in the 900-1500 
nm region. The excitation source was an 808-nm diode laser (RMPC lasers) at an output power 
of 160 mW and filtered by an 850-nm short-pass filter (Thorlabs), a 1000-nm short-pass filter 
(Thorlabs), an 1100-nm short-pass filter (Omega) and a 1300-nm short-pass filter (Omega). The 
excitation at 808 nm was intentionally chosen to balance absorption and scattering to afford 
maximum penetration depth of excitation light for in vivo imaging. The excitation beam was 
allowed to pass through an aqueous solution of pDA-PEG polymer in a 1 mm path cuvette 
(Starna Cells) and the emission was collected in the transmission geometry with a 900-nm long-
pass filter (Thorlabs) to reject the excitation light. The emitted fluorescence from the sample was 
directed into a spectrometer (Acton SP2300i) equipped with a liquid-nitrogen-cooled InGaAs 
linear array detector (Princeton OMA-V). The emission spectrum was corrected after raw data 
acquisition to account for the detector sensitivity profile and extinction feature of the filter using 
the MATLAB software. 
Determination of fluorescence quantum yield of pDA-PEG. Fluorescence quantum yield of 
the pDA-PEG polymer in water was measured in a similar way to a previous publication,
32
 using 
the NIR-II fluorescent IR-26 dye as the reference (quantum yield = 0.5%).
31
 For reference 
calibration on our setup, a stock solution of 1 mg·mL
-1
 IR-26 dissolved in 1,2-dichloroethane 
(DCE) was diluted to a DCE solution with its absorbance value of ~0.10 at 808 nm. Then this 
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sample was diluted using DCE to a series of samples with their absorbance values at 808 nm of 
~0.08, ~0.06, ~0.04 and ~0.02. Using these highly diluted samples with low absorbance 
minimized any secondary optical processes such as reabsorption and reemission effects. Then a 
total of five IR-26 solutions in DCE with linearly spaced concentrations (including the one with 
absorbance of ~0.10) were loaded into a 10-mm path fluorescence cuvette (Starna Cells) one at a 
time. The excitation source was an 808-nm diode laser (RMPC lasers) with a linewidth FWHM 
of 1.89 nm at an output power of 160 mW and filtered by an 850-nm short-pass filter (Thorlabs), 
a 1000-nm short-pass filter (Thorlabs), an 1100-nm short-pass filter (Omega) and a 1300-nm 
short-pass filter (Omega). The emission was collected in the transmission geometry with a 900-
nm long-pass filter (Thorlabs) to reject the excitation light and the emission spectrum was taken 
in the 900-1500 nm region. The same absorption and emission measurements were carried out 
for pDA-PEG polymers and SWNTs in aqueous solutions too. Then all emission spectra of both 
the reference and the samples were corrected after raw data acquisition to account for the 
detector sensitivity profile and the extinction profiles of the filters, and integrated in the 900-
1500 nm NIR-II region. The definition of quantum yield dictates that all emitted photons should 
be taken into account for quantum yield measurement.
65 In our quantum yield measurements, 
since an 808-nm laser is used, ideally the integration of the emission spectra should start from 
809 nm to cover the complete emission band; however, due to the limited choice of excitation 
and emission filters, we started the integration from 900 nm, which would give an 
underestimated quantum yield. Nonetheless, this underestimation would not be too much since 
one could see from the emission spectra that the emission dropped rapidly below 950 nm, 
meaning there would not be too much fluorescence emission under 900 nm. The integrated NIR-
II fluorescence intensity was plotted against absorbance at the excitation wavelength of 808 nm 
and fitted into a linear function. Two slopes, one obtained from the reference of IR-26 in DCE 
and the other from the sample (pDA-PEG or SWNT), were employed in the calculation of the 
quantum yield of the sample, based on equation (1) as follows, 
               
           
        
 (
       
    
)
 
    (1) 
where         and      are the refractive indices of water and DCE, respectively. 
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AFM imaging of pDA-PEG. AFM image of pDA-PEG was acquired with a Nanoscope IIIa 
multimode AFM in the tapping mode. The sample for imaging was prepared by drop-drying a 
highly diluted aqueous solution of pDA-PEG polymer at a mass concentration of 750 ng·L
-1
 onto 
the SiO2/silicon substrate without any post-processing steps. To plot the size distribution of the 
pDA-PEG polymeric nanoparticles, 100 nanoparticles were measured from the AFM images and 
their heights were used to generate the histogram of size distribution. Due to the effect of tip size 
convolution in AFM,
66
 the height measurement from the AFM micrograph, rather than the lateral 
size measurement, was used to measure the size of the nanoparticles deposited on the substrate. 
Dynamic light scattering (DLS) analysis of pDA-PEG. DLS was performed using a solution of 
pDA-PEG at 0.75 g·ml-1 in PBS in a 1-cm quartz cuvette. A PBS solution was used to mimic 
the ionic strength in blood because the hydrodynamic size of pDA-PEG was dependent on the 
ionic strength. The data was collected using a Brookhaven Instruments 90Plus Particle Size 
Analyzer. 
Cell incubation and staining. All cell culture media were supplemented with 10% fetal bovine 
serum, 100 μg·mL-1 streptomycin, 100 IU·mL-1 penicillin and L-glutamine. The human 
glioblastoma U87-MG cells were cultured in Low Glucose Dulbecco’s Modified Eagle Medium 
(DMEM), with 1 g·L
-1
 D-glucose and 110 mg·L
-1
 sodium pyruvate, in the presence of 5% CO2. 
Human breast cancer MDA-MB-468 cells were cultured in Leibovitz’s L-15 medium at 37 °C, 
CO2 free. Cells were maintained in a 37 ℃ incubator. For cell staining, cells were trypsinized 
before the as-made pDA-PEG-Erbitux bioconjugate was incubated with both EGFR-positive 
(MDA-MB-468) and EGFR-negative (U87-MG) cell lines at a concentration of 5 g·mL-1 at 4 ℃ 
for 1 h, followed by washing the cells with 1x PBS to remove all free, unbound pDA-PEG-
Erbitux bioconjugate in the suspension.  
NIR-II fluorescence imaging of cancer cells. Targeted cell imaging in the 1.0-1.7 m NIR-II 
window was carried out using a 658-nm laser diode with a 150 μm-diameter excitation beam 
focused by a ×50 objective lens (Olympus). The NIR-II fluorescence from pDA-PEG-Erbitux 
bioconjugate was collected using a liquid-nitrogen-cooled, 320 × 256 pixel, 2D InGaAs camera 
(Princeton Instruments 2D OMA-V). The excitation light was filtered out using a 900 nm and a 
1000 nm long-pass filter (Thorlabs) so that the intensity of each pixel in the camera represented 
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fluorescence in the 1.0-1.7 m NIR-II region. The exposure time was 3 s for all fluorescence 
images.  
Mouse Handling. All vertebrate animal experiments were performed under the approval of 
Stanford University’s Administrative Panel on Laboratory Animal Care (APLAC). 8-week old 
female BALB/c mice were obtained from Charles River and housed at the Research Animal 
Facility of Stanford under our approved animal protocols. Before hindlimb vessel imaging, all 
mice were anesthesized in a rodent anesthesia machine with 2 L·min
-1
 O2 gas flow mixed with 3% 
Isoflurane. Then the hair over the hindlimb skin was carefully removed using Nair to avoid 
causing wounds to the skin. Tail vein injection of the pDA-PEG contrast agent was carried out in 
dark and synchronized with the camera that started continuous image acquisition simultaneously. 
The injected dose was a 200 L bolus of the pDA-PEG in a 1× PBS solution at a mass 
concentration of 0.25 mg·mL
-1
. During the time course of imaging the mouse was kept 
anesthetized by a nose cone delivering 1.5 L·min
-1
 O2 gas mixed with 3% Isoflurane. 
Ultrafast video-rate NIR-II vessel imaging. Video-rate NIR-II vessel imaging was done in a 
similar manner as our previous publication.
3
 In brief, imaging was carried out on a homebuilt 
imaging setup consisting of a 2D InGaAs camera (Princeton Instruments 2D OMA-V). The 
excitation was provided by an optical-fiber-coupled 808-nm diode laser (RMPC Lasers), 
intentionally chosen to balance absorption and scattering to afford maximum penetration depth 
of excitation light for in vivo imaging. The high fluorescence quantum yield of the pDA-PEG 
also ensured sufficient emission for ultra-fast in vivo imaging despite the non-resonant excitation 
under 808 nm. The light was collimated by a collimator with a focal length of 4.5 mm (ThorLabs) 
and filtered by an 850-nm and a 1000-nm shortpass filter (ThorLabs). The power density of the 
excitation laser at the imaging plane was 140 mW·cm
-2
, significantly lower than the reported 
safe exposure limit of 329 mW·cm
-2
 at 808 nm.
67
 The emitted fluorescence from the mouse was 
allowed to pass through a 900 nm and a 1000 nm long-pass filter (Thorlabs) and to be focused 
onto the InGaAs detector by a lens pair consisting of two NIR achromats (200 and 75 mm; 
Thorlabs). The distance between the two NIR achromats was adjusted to have only one hindlimb 
of the mouse included in the field of view. The camera was set to expose continuously using the 
LabVIEW software with an exposure time of 20 ms. NIR-II images were acquired with a frame 
rate of 25.6 fps due to a 19 ms overhead time during readout. 
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In vitro toxicity study of pDA-PEG. We determined the in vitro toxicity of pDA-PEG by MTS 
assay using a CellTiter96 kit (Promega) on human breast cancer MDA-MB-468 cells. To 
evaluate how the surfactant coating of the pDA polymer affected the nanoparticles’ in vitro 
toxicity, we coated the pDA polymer (the same formulation as in Fig. 1) with DSPE-mPEG and 
poly(maleic anhydride-alt-1-octadecene)methoxy(polyethyleneglycol, 5kDa) (C18-PMH-mPEG), 
respectively, where DSPE-mPEG has one linear PEG chain while C18-PMH-mPEG has many 
branched PEG chains. For in vitro toxicity study, approximately 5,000 MDA-MB-468 cells were 
incubated per well with 100 μl of Leibovitz’s L-15 medium spiked with pDA-DSPE-mPEG or 
pDA-C18-PMH-mPEG at serially diluted concentrations (n = 6 for each concentration). The 
cells were kept at 37 °C in a humidified atmosphere for 36 h in the absence of CO2. 100% MDA-
MB-468 cell medium without any pDA-PEG was taken as the positive control while MDA-MB-
468 cell medium spiked with 20 μM Doxil® was taken as the negative control. Immediately 
before addition of 15 μl of CellTiter96 for the colorimetric assay, the polymer-spiked medium 
was removed from each well in the plate and replaced with fresh MDA-MB-468 cell growth 
medium. This would prevent any interference in the absorbance readings from the intrinsic color 
of pDA-PEG. After 1.5 h, the color change was quantified using a plate reader, which took 
absorbance readings at 485 nm. Cell viability was plotted as a fraction of the absorbance value of 
the positive control wells incubated without any pDA-PEG after baseline subtraction of the 
absorbance for medium alone. The negative control wells had an average cell viability value of 
~60% after 36 h of incubation, which was as expected. We found from the in vitro toxicity study 
that pDA-DSPE-mPEG has a half maximal inhibitory concentration (IC50) level of ~30 g/mL, 
while pDA-C18-PMH-mPEG has an IC50 level of >150 g/mL. The pDA-PEG solution could 
not be further concentrated to an even higher concentration, preventing us from measuring the 
cell viability under an incubation concentration of >150 g/mL. It is also noteworthy that the 
linear or branched PEG coating did not alter the fluorescence quantum efficiency to a noticeable 
level.  
Hydrodynamic size tuning of pDA-PEG nanoparticles. The hydrodynamic size tuning was 
performed by coating the pDA polymer with surfactants of different PEG molecular weights (2 
kDa and 5 kDa) and changing the initial pDA concentration in the THF solution (0.025-0.075 
mg/mL; please see the “Preparation of pDA-PEG and pDA-PEG-NH2” section in Methods) 
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before mixing with 1.1 mg/mL DSPE-mPEG in water. After the pDA-PEG nanoparticles were 
made in each synthesis condition, dynamic light scattering (DLS) analysis was performed to 
evaluate each sample’s hydrodynamic diameter as a function of initial pDA concentration in the 
THF solution and the molecular weight of PEG in the surfactant (please see the “Dynamic light 
scattering (DLS) analysis of pDA-PEG” section in Methods). The dependence of pDA-PEG 
hydrodynamic size on initial pDA concentration and PEG molecular weight is plotted in 
Supplementary Fig. 13, showing that both smaller PEG and lower initial concentration of pDA 
favor the formation of smaller pDA-PEG nanoparticles in aqueous solution. However, it is 
noteworthy that DLS was not able to discriminate the ‘empty’ nanoparticles without any pDA 
molecules loaded inside, and therefore the size distribution of the measured hydrodynamic 
diameters below ~4 nm could be due to the micelles formed by the DSPE-mPEG surfactants 
only.  
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Figures 
 
Figure 1 | Scheme for the Synthesis of pDA Polymer. This scheme shows the chemical 
structures of the two monomers M1 and M2, along with the structure of the pDA polymer, 
poly(benzo[1,2-b:3,4-b']difuran-alt-fluorothieno-[3,4-b]thiophene). 
  
M1 M2 pDA
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Figure 2 | Characterizations of pDA-PEG nanoparticle. (a) A schematic of the pDA-PEG 
nanoparticle showing a hydrophobic polymer core and hydrophilic PEG shell. (b) A typical 
AFM image of pDA-PEG nanoparticles deposited on a silicon substrate. Due to the effect of tip 
size convolution in AFM,
66
 the height measurement from the AFM micrograph, rather than the 
lateral size measurement, was used to measure the size of the nanoparticles deposited on the 
substrate. The lateral scale bar in b indicates 100 nm. (c) Absorption and emission spectra of 
pDA-PEG, featuring a large Stokes shift of ~ 400 nm. (d) An NIR-II fluorescence image of an 
aqueous solution of pDA-PEG taken in the range of 1.0-1.7 m NIR-II window under an 
excitation of 808 nm. (e) Fluorescence stability of pDA-PEG in different media including water, 
PBS and serum. The error bars were obtained by taking the standard deviation of all pixel 
intensities within an ROI covering the solution in the 1-mm cuvette, as shown in 
Supplementary Fig. 8. (f) Photostability curves of pDA-PEG in water, PBS and serum under 
continuous 808-nm illumination. pDA-PEG in serum exhibits the lowest degree of 
photobleaching (<10%) among the three. 
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Figure 3 | Molecular Cell Imaging with pDA-PEG-Erbitux. (a) A schematic showing the 
structure of pDA-PEG-Erbitux bioconjugate, where the anti-EGFR antibody (Erbitux) selectively 
targets EGFR on the cell membrane of an MDA-MB-468 cell. (b&c) White-light (b) and NIR-II 
(c) fluorescence images of EGFR positive MDA-MB-468 cells incubated with the pDA-PEG-
Erbitux bioconjugate, showing positive staining of cells. (d&e) White-light (d) and NIR-II (e) 
fluorescence images of EGFR negative U87-MG cells incubated with the pDA-PEG-Erbitux 
bioconjugate, without obvious staining of the cells. The scale bar in e indicates 40 m, which 
applies to all images shown in b-e. (f) Average NIR-II fluorescence of EGFR positive MDA-
MB-468 cells and negative U87-MG cells, showing a positive/negative ratio of ~5.8. The error 
bars in f were obtained by taking the standard deviation of average fluorescence intensity from 
20 cells in each NIR-II fluorescence image. 
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Figure 4 | Ultrafast NIR-II Imaging of Arterial Blood Flow. (a) A time course of NIR-II 
fluorescence images of a mouse hindlimb immediately following intravenous injection of pDA-
PEG, showing the blood flow front moving inside the femoral artery (indicated by red arrows). 
The frame rate of imaging is 25.6 fps with an exposure time of 20 ms and an instrument 
overhead time of 19 ms. (b) A plot of the distance travelled by the blood flow front as a function 
of time. The linear fit reveals an average blood velocity of 4.36 cm·s
-1
 in the femoral artery. (c) 
A plot of instantaneous velocity (derived by dividing flow front traveled distance between two 
consecutive frames by the time interval of 39 ms) as a function of time, revealing periodic 
changes of instantaneous velocity corresponding to cardiac cycles. (d) An NIR-II fluorescence 
image of the same mouse hindlimb after full perfusion of pDA-PEG-containing blood into the 
hindlimb, upon which the fluorescence intensity in the hindlimb became unchanging. The scale 
bars in a&d indicate 5 mm.   
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Figure 5 | Resolving Waveform Blood Flow Pattern with pDA. (a&b) An NIR-II fluorescence 
image (a) of the mouse femoral artery, where the fluorescence intensity inside the region of 
interest (ROI) red box is integrated and plotted as a function of time in (b), showing an 
increasing profile with humps corresponding to ventricular ejections of cardiac cycles. The scale 
bar in a indicates 5 mm. (c) NIR-II fluorescence intensity plotted as a function of time, after a 
linear increasing baseline is subtracted from the plot shown in b, featuring 5 cardiac cycles in the 
plot. (d-j) Time course NIR-II fluorescence images of the red box area shown in a, after 
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subtraction of a time-dependent linearly-increasing background given by the baseline in b. Note 
that these seven images correspond to a complete cardiac cycle from 312 ms to 546 ms. See 
Supplementary Movie 2 for a video showing the real-time evolution of the linear-background 
subtracted fluorescence intensity. The scale bar in d indicates 1 mm, which applies to all images 
of d-j.(k) Time point of NIR-II fluorescence spikes corresponding to ventricular ejections shown 
in c, plotted over several heart pulses (black squares).  The data is fitted to a linear function with 
its slope of 206.7 ms per pulse corresponding to the period of each cardiac cycle. 
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Supplementary Figures 
 
Supplementary Figure 1 | 
1
H NMR Spectrum of the Monomer M1. The peaks in the NMR 
spectrum are assigned as follows: 2.95 (t, 2H), 1.76 (m, 2H), 1.39-1.30 (m, 10H), 0.91 (t, 3H). 
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Supplementary Figure 2 | 
19
F NMR Spectrum of the Monomer M1. The peak in the 
19
F NMR 
spectrum is assigned as follows:  -129 ppm (s, Ar-F) 
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Supplementary Figure 3 | 
1
H NMR Spectrum of the Monomer M2. The peaks in the NMR 
spectrum are assigned as follows: 7.06 (s, 2H), 4.35 (d, 4H), 1.78 (m, 2H), 1.37-1.70 (m, 16 H), 
0.96-1.03 (m, 12 H), 0.44 (s, 18 H). 
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Supplementary Figure 4 | 
1
H NMR Spectrum of the pDA Polymer. The peaks in the NMR 
spectrum are assigned as follows: 6.80 (br, 2H), 4.31 (br, 4H), 3.06 (br, 2H), 2.01-1.21 (br, 30H), 
0.81-1.21 (br, 15H). The inset shows a zoomed-in view of the spectrum in the 2.5-7.3 ppm 
region.  
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Supplementary Figure 5 | Gel Permeation Chromatography (GPC) Spectrum of pDA. 
Molecular weight and polydispersity of the polymer are listed as follows: Mn (number-average 
molecular weight): 16,192; Mw (weight-average molecular weight): 30,991; Mp (peak molecular 
weight): 24,941; PDI (polydispersity index):1.91.  
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Supplementary Figure 6 | Size Analysis of pDA-PEG. (a) A bar chart showing the particle size 
histogram of dried pDA-5k-PEG nanoparticles from the height measurements of the AFM image 
shown in Fig. 2b (red bars), and the size distribution of the same pDA-5k-PEG sample in a 1x 
PBS solution based on DLS measurement (blue bars). (b) The size breakdown of the pDA-5k-
PEG complex showing the polymer core of ~3 nm (measured by AFM for the collapsed 
nanoparticle) and the overall size of ~17 nm when the PEG chains were hydrated and extended 
(measured by DLS in an aqueous solution). 
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Supplementary Figure 7 | Quantum Yield Measurements. (a) UV-Vis-NIR absorption spectra 
of a series of the IR-26 reference solutions in DCE with increasing concentrations. (b) NIR-II 
emission spectra of the IR-26 reference solutions shown in a under an excitation of 808 nm. (c) 
Integrated NIR-II fluorescence intensity plotted as a function of absorbance at 808 nm for IR-26 
reference solutions based on the measurements in a and b. The data was fitted into a linear 
function with a slope of 1.488×10
6
. (d) UV-Vis-NIR absorption spectra of a series of the pDA-
PEG polymer solutions in water with increasing concentrations. (e) NIR-II emission spectra of 
the pDA-PEG polymer solutions shown in d under an excitation of 808 nm. (f) Integrated NIR-II 
fluorescence intensity plotted as a function of absorbance at 808 nm for pDA-PEG polymer 
solutions based on the measurements in d and e. The data was fitted into a linear function with a 
slope of 5.870×10
6
, giving a measured quantum yield of 1.7 ± 0.11%. (g) UV-Vis-NIR 
absorption spectra of a series of SWNT solutions in water with increasing concentrations. (h) 
NIR-II emission spectra of the SWNT solutions shown in g under an excitation of 808 nm. (i) 
Integrated NIR-II fluorescence intensity plotted as a function of absorbance at 808 nm for SWNT 
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solutions based on the measurements in g and h. The data was fitted into a linear function with a 
slope of 1.350×10
6
, giving a measured quantum yield of 0.4 ± 0.01%.  
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Supplementary Figure 8 | Photostability of the pDA-PEG Polymer in Different Media. The 
top row shows the NIR-II fluorescence images of pDA-PEG polymer in water, PBS and serum 
before continuous 808-nm excitation, at the same concentration of 7.5 g/mL. The bottom row 
shows the NIR-II fluorescence images of the same samples after continuous 808-nm excitation 
for 1 h. The scale bar indicates 1 cm.  
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Supplementary Figure 9 | Origin of ‘Dot’ Features in Fig. 5. (a) An NIR-II fluorescence 
image at 390 ms p.i., corresponding to the red box area shown in Fig. 5a, after subtraction of the 
baseline shown in Fig. 5b. The scale bar indicates 1 mm. (b) The same basedline-subtracted 
NIR-II image as in a, with all ‘dot’ features labeled as A, C, E, G, I and K (red), and the 
locations between two neighboring dots labeled as B, D, F, H and J (green). (c) NIR-II 
fluorescence intensity and vessel diameter measured at all points labeled from A to K in b, 
showing in-phase changes between the two measurements at these points. A positive correlation 
between the local blood volume and the NIR-II fluorescence intensity has been found, suggesting 
a larger lumen (i.e., a larger diameter) of the vessel could hold more blood with more NIR-II 
fluorescent agents, and thus appeared brighter than neighboring vessel segments, resulting in the 
‘dot’ features after subtracting a constant baseline from all pixels in the NIR-II fluorescence 
image.  
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Supplementary Figure 10 | pDA Polymers with Tunable Absorption and Emission 
Properties. The chemical structures of four different pDA molecules are shown in a-d, along 
with their absorption and emission spectra (e&f) revealing the emission wavelengths tuned in the 
range of 1050-1350 nm. 
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Supplementary Figure 11 | Blood Flow Tracking Inside a Capillary Vessel. (a) Time course 
NIR-II fluorescence images of a capillary vessel after injection of pDA-PEG nanoparticles under 
an excitation of 808 nm. A bolus of injected pDA-PEG travelling upwards along a 6-m wide 
capillary vessel (outlined in red dashed lines) can be visualized in the images, as indicated by the 
white arrows. The scale bar indicates 20 m. (b) A plot of the distance travelled by the bolus of 
injected pDA-PEG as a function of time. The linear fit reveals an average blood velocity of 55.2 
m/s in this particular capillary vessel, ~800× slower than in the femoral artery and also much 
less affected by the cardiac output cycles. 
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Supplementary Figure 12 | Imaging Regional Blood Redistribution with pDA-PEG. (a) A 
white light image showing the mouse with heat-induced inflammation in the right hindlimb (left 
to the viewer). This image was taken at ~5 h after the inflammation was induced. (b-h) Time 
course NIR-II fluorescence images of the mouse at different times after the inflammation was 
induced. The scale bar in b indicates 10 mm and applies to all NIR-II fluorescence images. (i) 
Average NIR-II fluorescence intensity plotted as a function of time after induced inflammation 
in the control and the inflamed hindlimbs. The error bars in i were obtained by taking the 
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standard deviation of the NIR-II fluorescence intensity of all pixels in each hindlimb at every 
time point after induced inflammation. (j) The ratio of the NIR-II fluorescence intensity in the 
inflamed hindlimb over that in the control hindlimb, plotted as a function of time after the 
induced inflammation. The error bars in j were obtained by propagating the errors associated 
with the corresponding control and inflamed hindlimbs shown in i.  
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Supplementary Figure 13 | Size Tunability of the pDA-PEG Nanoparticles. This plot shows 
the size distribution of the pDA-PEG nanoparticles measured by DLS and plotted as a function 
of initial pDA concentration in the THF solution during the synthesis of pDA-PEG nanoparticles 
and the molecular weight of the surfactant DSPE-mPEG. Note that the measured hydrodynamic 
diameters of pDA-2k-PEG in the range of 2-6 nm (the bottom left data point) may contain some 
‘empty’ surfactant micelles without any pDA molecules loaded inside (2-4 nm in diameter). The 
error bars reflect the standard deviation of the measured hydrodynamic diameter distribution of 
each corresponding sample. 
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Supplementary Note 1. | The dynamic range of blood velocity measurement with the NIR-II 
fluorescence of pDA-PEG. The dynamic range of velocity measurement using the pDA-PEG 
fluorophores is from 0 to ~640 mm/s, determined by both the optical properties (the NIR-II 
fluorescence brightness) of pDA-PEG and the speed of data acquisition of the camera used for 
dynamic imaging. The detailed derivation of the dynamic range is shown as follows. 
Since velocity is defined as distance / time, we need to find out the dynamic ranges of available 
time intervals of image acquisition and the measurable distance in our imaging system. The 
frame rate of dynamic fluorescence imaging (i.e., the inverse of time interval per image 
acquisition), which determines how fast we can track the blood flow in vivo, is given by 1 / 
(exposure time + overhead time). Here the exposure time needed for acquiring images with good 
quality is determined by the brightness of the pDA fluorophores, and the overhead time is 
determined by the rate at which the camera acquires and digitizes each image. The shortest 
possible exposure time is 20 ms (using the brightest pDA polymer we currently have), while the 
shortest possible overhead time of the camera is ~19 ms. Therefore, the maximum frame rate we 
can use for dynamic imaging is 1 / (20 ms + 19 ms) = 25.6 Hz (or 25.6 fps). Our imaging system 
is a low-pass system, meaning any frequency lower than 25.6 Hz is available by increasing the 
time interval between measurements. Therefore the dynamic range of temporal resolution is from 
0 to 25.6 Hz. 
On the other hand, by using different lens/objective sets to form images with different 
magnifications onto the camera, the measurable distance during dynamic imaging ranges from 1 
m (diffraction limit) to 25 mm (field of view limit). Since velocity is distance divided by time, 
one can derive the slowest and the fastest measurable blood velocity in our current setup using 
the pDA fluorophores as follows:  
The slowest measurable blood velocity = 1 m × 0 Hz = 0 mm/s 
The fastest measurable blood velocity = 25 mm × 25.6 Hz = 640 mm/s 
Therefore the dynamic range of measurable blood velocity in our current system using the pDA 
fluorophores is given as 0 to 640 mm/s. 
 
 
 
